No Data
No Data
3SBio Inc. Schedules Annual General Meeting
Both Individual Investors Who Control a Good Portion of 3SBio Inc. (HKG:1530) Along With Institutions Must Be Dismayed After Last Week's 3.5% Decrease
Key Insights 3SBio's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 25 investors have a majority stake in
A record high! The total number of clinical trials exceeded 4,000 in 2023
According to the report, in 2023, the total number of clinical trials registered on the drug clinical trial registration and information disclosure platform surpassed 4,000 for the first time, reaching 4,300 (in terms of CTR), the highest total number of registrations in history, an increase of 26.1% over the total number of registrations in 2022.
Sansheng Pharmaceutical (01530) spent HK$2,629,800 to buy back 409,000 shares on May 16
Sansheng Pharmaceutical (01530) announced that on May 16, 2024, the company spent HK$2,629,800...
Sansheng Pharmaceutical (01530.HK) spent HK$3.99 million to buy back 600,000 shares on May 13
Gelonghui, May 13 | Sansheng Pharmaceutical (01530.HK) announced that it spent HK$3.99 million to buy back 600,000 shares on May 13.
三生製藥:2023 年度報告
No Data